Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Placebo-Controlled Clinical Trial of Dapsone as a Glucocorticoid-Sparing Agent in Maintenance Phase Pemphigus Vulgaris

NCT00429533 is registered in ClinicalTrials.gov with Jacobus Pharmaceutical as lead sponsor.

NCT NCT00429533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00429533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Placebo-Controlled Clinical Trial of Dapsone as a Glucocorticoid-Sparing Agent in Maintenance Phase Pemphigus Vulgaris
Lead sponsor
Jacobus Pharmaceutical
Phase
Phase 2
Overall status
Terminated
Start date
November 30, 1996
Completion date
February 29, 2004
Enrollment
48
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

pemphigus vulgaris